1 |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.
|
2 |
Cramer JD, Burtness B, Le QT, et al. The changing therapeutic landscape of head and neck cancer[J]. Nat Rev Clin Oncol, 2019, 16(11): 669-683.
|
3 |
Huang H, Weng H, Chen J. m6A modification in Coding and Non-coding RNAs: roles and therapeutic implications in cancer[J]. Cancer Cell, 2020, 37(3): 270-288.
|
4 |
Liu J, Li K, Cai J, et al. Landscape and regulation of m6A and m6Am methylome across human and mouse tissues[J]. Mol Cell, 2020, 77(2): 426-440.e6.
|
5 |
Zhao X, Cui L. Development and validation of a m6A RNA methylation regulators-based signature for predic-ting the prognosis of head and neck squamous cell carcinoma[J]. Am J Cancer Res, 2019, 9(10): 2156-2169.
|
6 |
Terlizzi M, Casolaro V, Pinto A, et al. Inflammasome: cancer's friend or foe[J]. Pharmacol Ther, 2014, 143(1): 24-33.
|
7 |
Zhang B, Wu Q, Li B, et al. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer[J]. Mol Cancer, 2020, 19(1): 53.
|
8 |
Han D, Liu J, Chen C, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells[J]. Nature, 2019, 566(7743): 270-274.
|
9 |
Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape[J]. Genome Biol, 2017, 18(1): 220.
|
10 |
Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer[J]. Nat Rev Cancer, 2018, 18(5): 269-282.
|
11 |
Li Y, Xiao J, Bai J, et al. Molecular characterization and clinical relevance of m6A regulators across 33 cancer types[J]. Mol Cancer, 2019, 18(1): 137.
|
12 |
Shriwas O, Priyadarshini M, Samal SK, et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NA-NOG[J]. Apoptosis, 2020, 25(3/4): 233-246.
|
13 |
Zhao W, Cui Y, Liu L, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-Myc stability via YTHDF1-mediated m6A modification[J]. Mol Ther Nucleic Acids, 2020, 20: 1-12.
|
14 |
Ban Y, Tan P, Cai J, et al. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma[J]. Mol Oncol, 2020, 14(6): 1282-1296.
|
15 |
Tanabe A, Konno J, Tanikawa K, et al. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene[J]. Gene, 2014, 535(1): 24-32.
|
16 |
Fanale D, Iovanna JL, Calvo EL, et al. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility[J]. Expert Opin Ther Targets, 2014, 18(8): 841-850.
|
17 |
Cui Q, Shi H, Ye P, et al. m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells[J]. Cell Rep, 2017, 18(11): 2622-2634.
|
18 |
Cheng M, Sheng L, Gao Q, et al. The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network[J]. Oncogene, 2019, 38(19): 3667-3680.
|
19 |
Wu Y, Zhao W, Liu Y, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response[J]. EMBO J, 2018, 37(23): e99017.
|
20 |
Fischl H, Neve J, Wang Z, et al. hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles[J]. Nucleic Acids Res, 2019, 47(14): 7580-7591.
|
21 |
Li T, Hu PS, Zuo Z, et al. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma[J]. Mol Cancer, 2019, 18(1): 112.
|
22 |
Liu J, Zhang X, Chen K, et al. CCR7 Chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1α-mediated glycolysis[J]. Immunity, 2019, 50(3): 600-615.
|
23 |
Winkler R, Gillis E, Lasman L, et al. m6A modification controls the innate immune response to infection by targeting type I interferons[J]. Nat Immunol, 2019, 20(2): 173-182.
|
24 |
Wang H, Hu X, Huang M, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation[J]. Nat Commun, 2019, 10(1): 1898.
|